20 insiders reported 109 Form 4 transactions for ROCKET PHARMACEUTICALS, INC. (RCKT) over the past 18 months (most recent 2026-07-06). Recent activity: BOESS CARSTEN (Director) Buy 22,862 shares, SOUTHWELL DAVID P (Director) Buy 22,862 shares, Dolsten Mikael (Director) Buy 22,862 shares, WONG RODERICK (Director) Buy 27,832 shares, Malik Fady Ibraham (Director) Buy 22,862 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | BOESS CARSTEN | Director | Buy | 22,862 | $0 |
| 2026-07-06 | SOUTHWELL DAVID P | Director | Buy | 22,862 | $0 |
| 2026-07-06 | Dolsten Mikael | Director | Buy | 22,862 | $0 |
| 2026-07-06 | WONG RODERICK | Director | Buy | 27,832 | $0 |
| 2026-07-06 | Malik Fady Ibraham | Director | Buy | 22,862 | $0 |
| 2026-07-06 | Fong Peter | Director | Buy | 22,862 | $0 |
| 2026-05-21 | Militello John | See Remarks | Sell | 384 | $1,157 |
| 2026-05-21 | Wilson Martin | General Counsel | Sell | 662 | $1,995 |
| 2026-05-21 | Shah Gaurav | CEO | Sell | 2,409 | $7,261 |
| 2026-05-14 | Militello John | See Remarks | Sell | 855 | $3,083 |
| 2026-05-14 | Wilson Martin | General Counsel | Sell | 3,361 | $12,120 |
| 2026-05-14 | Shah Gaurav | CEO | Sell | 2,728 | $9,837 |
| 2026-05-11 | Chaudhuri Sarbani | See Remarks | Sell | 17,650 | $67,741 |
| 2026-02-20 | Militello John | See Remarks | Sell | 1,157 | $3,864 |
| 2026-02-20 | Shah Gaurav | CEO | Sell | 5,990 | $20,007 |
| 2026-02-20 | Wilson Martin | General Counsel | Sell | 1,376 | $4,596 |
| 2026-02-18 | Wilson Martin | General Counsel | Sell | 12,253 | $40,557 |
| 2026-02-18 | Shah Gaurav | CEO | Sell | 12,279 | $40,643 |
| 2026-02-18 | Militello John | See Remarks | Sell | 3,726 | $12,333 |
| 2026-02-13 | Chaudhuri Sarbani | See Remarks | Buy | 125,924 | $0 |
| 2026-02-13 | Rizvi Syed Ali-aamir | Chief Medical Officer | Buy | 61,963 | $0 |
| 2026-02-13 | Militello John | See Remarks | Buy | 29,982 | $0 |
| 2026-02-13 | Shah Gaurav | CEO | Buy | 286,028 | $0 |
| 2026-02-13 | Wilson Martin | General Counsel | Buy | 311,813 | $0 |
| 2026-02-13 | Stevens Christopher James | Chief Operating Officer | Buy | 61,963 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06